ArticleCanadian journal of gastroenterology & hepatology2022

Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center.

Jin-Xing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.